SANJAY CHAUDHURI: Open Payments
NPI 1548879877 · MONROE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,014 in 94 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $408 · 2025 $2,014
Food & beverage: $2,011Education: $2
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 8 | $334 |
| Alkermes, Inc. | 14 | $314 |
| Vanda Pharmaceuticals Inc. | 18 | $289 |
| Otsuka America Pharmaceutical, Inc. | 8 | $244 |
| ABBVIE INC. | 12 | $200 |
| Janssen Pharmaceuticals, Inc | 10 | $177 |
| Neurocrine BioSciences, Inc. | 6 | $118 |
| Lundbeck LLC | 5 | $95 |
| Tris Pharma Inc | 4 | $88 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $70 |
Products named: Auvelity, REXULTI, FANAPT, ARISTADA, VRAYLAR, SPRAVATO, INGREZZA, LYBALVI.
Industry payments across LA — which companies pay providers there.
